Biggest News Aggregation in the World
📰 Associate Chief News

Page 14 - Associate Chief News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Associate Chief. Real-time updates on events, politics, business and more.

People with depression may be more receptive to COVID-19 vaccine related misinformation

A general bias toward negativity-;or the tendency to focus on negative rather than positive information-;may exacerbate the spread of misinformation. Because depression may contribute to such negativity bias, a team led by investigators at Massachusetts General Hospital (MGH) examined whether people who experience depressive symptoms may be more receptive to misinformation related to COVID-19 vaccines.
United States Royh Perlis Emily Henderson Quantitative Health Department Of Psychiatry Massachusetts General Hospital

Froedtert Medical Director for Infection Prevention and Control talks about Omicron surge

Dr. Mary Beth Graham is the Medical Director for Infection Prevention and Control at Froedtert Hospital and Associate Chief of the Division of Infectious Disease at the Medical College of Wisconsin. She shares information on how to stay safe and equipped during the current Omicron variant surge.
South Africa United States United Kingdom Medical College Of Wisconsin Great Britain Mary Beth Graham
Source: wuwm.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Pharmacy Residency Program | VA Eastern Kansas Health Care

The VA Eastern Kansas Health Care System (VAEKHCS) PGY-1 Pharmacy Residency is a one year post graduate experiential educational program which provides a well-rounded training experience with focus on ambulatory care, mental health, and geriatrics. Residents will gain experience through various learning experiences such as Ambulatory/Primary Care, Anticoagulation, Acute Medicine, Geriatrics, Mental Health, Home Based Primary Care, Pharmacy Administration and Leadership. Residents will have a ...
Creighton University United States Junction City North Carolina Rhode Island Grand Island
Source: va.gov

Daiichi Sankyo: Datopotamab Deruxtecan Continues to Show Promising Durable Response and Disease Control in Patients with Metastatic Triple Negative Breast Cancer

Updated data from the TNBC cohort of the TROPION-PanTumor01 phase 1 trial of Daiichi Sankyo and AstraZeneca's datopotamab deruxtecan featured as oral presentation at SABCS New data from the TROPION-PanTumor01
United States Masashi Kawase Iane Krop Daiichi Sankyo Daiichi Sankyo Europe Gmb Cristian Massacesi

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science